Cardinal Health raises profit outlook on drug demand
Cardinal Health raised its annual profit forecast to between $10.7 and $10.8 per share. This update follows strong demand for specialty drugs and branded medicines.
Xurve View
Insights:
Xurve View
CARDINAL HEALTH INC raised its 2026 adjusted profit forecast to $10.70–$10.80 per share after specialty drug demand drove a third-quarter earnings beat. The new guidance sits above the previous range of $10.15–$10.35 and exceeds LSEG analyst expectations of $10.31. Rising volumes of high-margin medicines for complex conditions are offsetting revenue misses in traditional wholesale distribution for the United States-based firm.
